Pub Date : 2026-01-07DOI: 10.47717/turkjsurg.2025.2025-7-7
Sertaç Ata Güler, Salih Efe Gül, Zeynep İrem Yarımbaş, Osman Demir
Objective: Medical visual documentation is an important part of medical education. It provides numerous benefits to both. This article argues for the integration of medical photography into medical education.
Material and methods: A medical visualization and documentation elective course was offered to second-year students at the Kocaeli University Faculty of Medicine. At the end of the 14-week program, a questionnaire was administered to students who participated in the course. The survey results were analyzed using data analysis programs.
Results: According to the survey results, the students stated that the elective course positively impacted their education and experience as future doctors.
Discussion: In many medical schools, both in Turkey and around the world, medical photography training is not integrated into medical education. This presents challenges for medical education and physicians. However, these difficulties can be overcome by providing integrated training and courses for doctors.
{"title":"Integration of medical visual documentation into medical education, benefits for medicine, education and treatment.","authors":"Sertaç Ata Güler, Salih Efe Gül, Zeynep İrem Yarımbaş, Osman Demir","doi":"10.47717/turkjsurg.2025.2025-7-7","DOIUrl":"https://doi.org/10.47717/turkjsurg.2025.2025-7-7","url":null,"abstract":"<p><strong>Objective: </strong>Medical visual documentation is an important part of medical education. It provides numerous benefits to both. This article argues for the integration of medical photography into medical education.</p><p><strong>Material and methods: </strong>A medical visualization and documentation elective course was offered to second-year students at the Kocaeli University Faculty of Medicine. At the end of the 14-week program, a questionnaire was administered to students who participated in the course. The survey results were analyzed using data analysis programs.</p><p><strong>Results: </strong>According to the survey results, the students stated that the elective course positively impacted their education and experience as future doctors.</p><p><strong>Discussion: </strong>In many medical schools, both in Turkey and around the world, medical photography training is not integrated into medical education. This presents challenges for medical education and physicians. However, these difficulties can be overcome by providing integrated training and courses for doctors.</p>","PeriodicalId":23374,"journal":{"name":"Turkish Journal of Surgery","volume":" ","pages":""},"PeriodicalIF":0.6,"publicationDate":"2026-01-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145918496","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-07DOI: 10.47717/turkjsurg.2025.2025-7-15
Kyoyoung Park, Jane Chungyoon Kim, Sa-Hong Kim, Jeesun Kim, Hee Seung Kim, Young Min Cho, Choong Ho Shin, Hyuk-Joon Lee
High-grade serous ovarian cancer (HGSOC) is the most lethal gynecologic malignancy, typically affecting postmenopausal women. BRCA1 mutation carriers are at increased risk of developing early-onset disease. While bariatric surgery reduces the incidence of several obesity-related cancers, its potential impact on hormonally driven malignancies in genetically predisposed individuals remains unclear. We report a rare case of early-onset HGSOC in a 21-year-old woman with morbid obesity and type 2 diabetes who underwent Roux-en-Y gastric bypass in 2010. Following significant weight loss, she regained regular menstruation and discontinued insulin therapy. After progressive weight regain, she underwent revisional bariatric surgery in 2020. Three years later, she presented with an ovarian cyst and elevated tumor markers. Imaging suggested malignancy, and biopsy confirmed HGSOC with a BRCA1 mutation. The patient underwent optimal cytoreductive surgery followed by chemotherapy and commenced olaparib maintenance therapy. As of September 2024, she remains disease-free. This case raises the concern that bariatric surgery, by restoring ovulatory function and altering metabolic and hormonal balance, may unmask a latent susceptibility to cancer in genetically predisposed patients. The temporal association between metabolic surgery and early-onset ovarian cancer warrants further investigation into postoperative hormonal shifts and cancer surveillance strategies. Bariatric surgery in women with hereditary cancer syndromes should be approached with caution. Preoperative genetic counseling, multidisciplinary assessment, and long-term oncologic surveillance are essential to ensure patient safety.
{"title":"A case of early-onset ovarian cancer following bariatric surgery: Highlighting the need for caution in genetically predisposed obese patients.","authors":"Kyoyoung Park, Jane Chungyoon Kim, Sa-Hong Kim, Jeesun Kim, Hee Seung Kim, Young Min Cho, Choong Ho Shin, Hyuk-Joon Lee","doi":"10.47717/turkjsurg.2025.2025-7-15","DOIUrl":"https://doi.org/10.47717/turkjsurg.2025.2025-7-15","url":null,"abstract":"<p><p>High-grade serous ovarian cancer (HGSOC) is the most lethal gynecologic malignancy, typically affecting postmenopausal women. BRCA1 mutation carriers are at increased risk of developing early-onset disease. While bariatric surgery reduces the incidence of several obesity-related cancers, its potential impact on hormonally driven malignancies in genetically predisposed individuals remains unclear. We report a rare case of early-onset HGSOC in a 21-year-old woman with morbid obesity and type 2 diabetes who underwent Roux-en-Y gastric bypass in 2010. Following significant weight loss, she regained regular menstruation and discontinued insulin therapy. After progressive weight regain, she underwent revisional bariatric surgery in 2020. Three years later, she presented with an ovarian cyst and elevated tumor markers. Imaging suggested malignancy, and biopsy confirmed HGSOC with a BRCA1 mutation. The patient underwent optimal cytoreductive surgery followed by chemotherapy and commenced olaparib maintenance therapy. As of September 2024, she remains disease-free. This case raises the concern that bariatric surgery, by restoring ovulatory function and altering metabolic and hormonal balance, may unmask a latent susceptibility to cancer in genetically predisposed patients. The temporal association between metabolic surgery and early-onset ovarian cancer warrants further investigation into postoperative hormonal shifts and cancer surveillance strategies. Bariatric surgery in women with hereditary cancer syndromes should be approached with caution. Preoperative genetic counseling, multidisciplinary assessment, and long-term oncologic surveillance are essential to ensure patient safety.</p>","PeriodicalId":23374,"journal":{"name":"Turkish Journal of Surgery","volume":" ","pages":""},"PeriodicalIF":0.6,"publicationDate":"2026-01-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145913187","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
We present a rare case of co-occurrence of Strongyloides stercoralis (S. stercoralis) infection and newly diagnosed pancreatic adenocarcinoma in a 71-year-old female who presented with new-onset jaundice and right upper quadrant abdominal pain. The patient had eosinophilia, recurrent Escherichia coli cholangitis, and a strong family history of jaundice in an endemic region. S. stercoralis larvae were identified on histopathological examination following pancreaticoduodenectomy. Notably, ivermectin treatment attenuated the delayed postoperative gastric emptying that had not responded to conventional management, including nasogastric decompression or drainage of a perigastric collection. While S. stercoralis can cause obstructive jaundice and pancreatic masses, this case highlights the importance of considering parasitic infections in patients from endemic areas or with immunosuppressive conditions who present with abdominal symptoms, particularly to avoid unnecessary interventions and prevent clinical deterioration.
{"title":"Delayed gastric emptying associated with <i>Strongyloides stercoralis</i> infection and pancreatic adenocarcinoma.","authors":"Özgür Aktaş, Gizem Yasa, Oğuz Usta, Sidar Çöpür, Burcu Saka, Yeşim Beşli, Duygu Karahacıoğlu, Gürkan Tellioğlu, Önder Ergönül","doi":"10.47717/turkjsurg.2025.2025-4-39","DOIUrl":"https://doi.org/10.47717/turkjsurg.2025.2025-4-39","url":null,"abstract":"<p><p>We present a rare case of co-occurrence of <i>Strongyloides stercoralis</i> (<i>S. stercoralis</i>) infection and newly diagnosed pancreatic adenocarcinoma in a 71-year-old female who presented with new-onset jaundice and right upper quadrant abdominal pain. The patient had eosinophilia, recurrent Escherichia coli cholangitis, and a strong family history of jaundice in an endemic region. <i>S. stercoralis</i> larvae were identified on histopathological examination following pancreaticoduodenectomy. Notably, ivermectin treatment attenuated the delayed postoperative gastric emptying that had not responded to conventional management, including nasogastric decompression or drainage of a perigastric collection. While <i>S. stercoralis</i> can cause obstructive jaundice and pancreatic masses, this case highlights the importance of considering parasitic infections in patients from endemic areas or with immunosuppressive conditions who present with abdominal symptoms, particularly to avoid unnecessary interventions and prevent clinical deterioration.</p>","PeriodicalId":23374,"journal":{"name":"Turkish Journal of Surgery","volume":" ","pages":""},"PeriodicalIF":0.6,"publicationDate":"2026-01-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145913231","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-07DOI: 10.47717/turkjsurg.2025.2025-8-12
Melih Akın, Defne Turan, Tamer Kamacı
Isolated common bile duct (CBD) injuries following blunt abdominal trauma are exceptionally rare in infants and often present a diagnostic challenge. Due to the retroperitoneal location of the CBD and the potentially mild peritoneal response to bile leakage, early symptoms may be subtle or absent. As a result, diagnosis is frequently delayed. We present a case of a 2-year-old child who was diagnosed on the 14th day after blunt trauma caused by a falling television unit. Imaging and surgical findings confirmed an isolated CBD injury. The patient was treated with the two-stage surgical approach using transcystic duct catheter drainage followed by delayed reconstruction. The initial procedure involved damage control surgery, including biliary drainage via a transcystic duct catheter and thorough peritoneal irrigation. Four months later, the definitive reconstruction was performed with a Roux-en-Y hepaticojejunostomy. This case emphasizes that isolated CBD injuries, though rare in infants, can follow blunt abdominal trauma and may present with delayed symptoms due to bile's low peritoneal irritancy. This case underscores the rarity and novelty of the transcystic duct catheter approach when managing bile leakage in an infant prior to definitive surgical reconstruction.
{"title":"Delayed diagnosis of isolated common bile duct injury in an infant: Efficacy of transcystic duct catheter in staged surgical management.","authors":"Melih Akın, Defne Turan, Tamer Kamacı","doi":"10.47717/turkjsurg.2025.2025-8-12","DOIUrl":"https://doi.org/10.47717/turkjsurg.2025.2025-8-12","url":null,"abstract":"<p><p>Isolated common bile duct (CBD) injuries following blunt abdominal trauma are exceptionally rare in infants and often present a diagnostic challenge. Due to the retroperitoneal location of the CBD and the potentially mild peritoneal response to bile leakage, early symptoms may be subtle or absent. As a result, diagnosis is frequently delayed. We present a case of a 2-year-old child who was diagnosed on the 14th day after blunt trauma caused by a falling television unit. Imaging and surgical findings confirmed an isolated CBD injury. The patient was treated with the two-stage surgical approach using transcystic duct catheter drainage followed by delayed reconstruction. The initial procedure involved damage control surgery, including biliary drainage via a transcystic duct catheter and thorough peritoneal irrigation. Four months later, the definitive reconstruction was performed with a Roux-en-Y hepaticojejunostomy. This case emphasizes that isolated CBD injuries, though rare in infants, can follow blunt abdominal trauma and may present with delayed symptoms due to bile's low peritoneal irritancy. This case underscores the rarity and novelty of the transcystic duct catheter approach when managing bile leakage in an infant prior to definitive surgical reconstruction.</p>","PeriodicalId":23374,"journal":{"name":"Turkish Journal of Surgery","volume":" ","pages":""},"PeriodicalIF":0.6,"publicationDate":"2026-01-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145913226","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-07DOI: 10.47717/turkjsurg.2025.2025-10-20
Ecem Güçlü Öztürk, Beliz Bilgili, Beyza B Özkurt, Özer Öztürk
Objective: Hip fractures are common in older adults and are associated with increased morbidity and mortality. Although multimodal anesthesia with peripheral nerve blocks is recommended, the superiority of specific block methods remains unclear. This study compared the postoperative analgesic efficacy of the suprainguinal fascia iliaca block (SFIB) and lumbar erector spinae plane block (LESPB) in patients who underwent hip fracture surgery.
Material and methods: This single-center, single-blind, randomized controlled trial was conducted at a university hospital (Marmara University Faculty of Medicine, İstanbul, Türkiye) between August 2022 and May 2023. Patients received SFIB, LESPB, or no block before spinal anesthesia. No block-related complications were observed. Postoperative analgesia was provided using patient-controlled intravenous morphine, with tramadol administered as rescue analgesia for NRS pain scores above 4. The primary outcome was 24-hour total opioid consumption. Secondary outcomes included opioid consumption at 6 and 48 hours, pain scores, rescue analgesia requirements, and time to discharge from the intensive care unit and hospital.
Results: A total of 63 patients (mean age 78.5±14.0 years; 46 females and 17 males) with American Society of Anesthesiologists I-III undergoing hip fracture surgery were randomized to SFIB (n=23), LESPB (n=22), or control (n=22). During the first 24 hours, opioid consumption were higher in the control group [18 (9-24.5); p=0.002]. Post-hoc analysis showed a significant difference between the control and SFIB groups [6 (4-9); p<0.001]. The LESPB [13 (5-22)] and control groups were comparable (p>0.016).
Conclusion: SFIB provided the greatest reduction in postoperative opioid use during the first 24 hours after hip fracture surgery. While LESPB appears to be an alternative to SFIB, it produced a reduction in opioid consumption similar to that observed in the control group. Suprainguinal FIB should be prioritized as a component of multimodal analgesia for these surgeries.
目的:髋部骨折在老年人中很常见,并且与发病率和死亡率增加有关。虽然多模态麻醉推荐周围神经阻滞,但具体阻滞方法的优越性尚不清楚。本研究比较了腹股沟上髂筋膜阻滞(SFIB)和腰椎竖脊肌平面阻滞(LESPB)在髋部骨折患者术后的镇痛效果。材料和方法:该单中心、单盲、随机对照试验于2022年8月至2023年5月在一所大学医院(马尔马拉大学医学院,İstanbul, t rkiye)进行。患者在脊髓麻醉前接受SFIB、LESPB或无阻滞。未见阻滞相关并发症。术后采用患者自行静脉注射吗啡镇痛,对NRS疼痛评分在4分以上的患者给予曲马多作为抢救性镇痛。主要终点是24小时阿片类药物总消耗量。次要结局包括6小时和48小时的阿片类药物消耗、疼痛评分、抢救镇痛需求以及从重症监护病房和医院出院的时间。结果:美国麻醉医师学会I-III期髋部骨折手术患者共63例(平均年龄78.5±14.0岁,女性46例,男性17例)被随机分为SFIB组(n=23)、LESPB组(n=22)和对照组(n=22)。在最初的24小时内,对照组的阿片类药物消耗量更高[18 (9-24.5);p = 0.002)。事后分析显示,对照组和SFIB组之间存在显著差异[6 (4-9);p0.016)。结论:SFIB在髋部骨折术后24小时内最大程度地减少了阿片类药物的使用。虽然LESPB似乎是SFIB的替代方案,但它产生了与对照组相似的阿片类药物消耗减少。腹股沟上FIB应优先作为这些手术中多模式镇痛的一个组成部分。
{"title":"Comparison of ultrasound-guided suprainguinal fascia iliaca block and lumbar erector spinae plane block in hip fracture: A single-blind randomized controlled trial.","authors":"Ecem Güçlü Öztürk, Beliz Bilgili, Beyza B Özkurt, Özer Öztürk","doi":"10.47717/turkjsurg.2025.2025-10-20","DOIUrl":"https://doi.org/10.47717/turkjsurg.2025.2025-10-20","url":null,"abstract":"<p><strong>Objective: </strong>Hip fractures are common in older adults and are associated with increased morbidity and mortality. Although multimodal anesthesia with peripheral nerve blocks is recommended, the superiority of specific block methods remains unclear. This study compared the postoperative analgesic efficacy of the suprainguinal fascia iliaca block (SFIB) and lumbar erector spinae plane block (LESPB) in patients who underwent hip fracture surgery.</p><p><strong>Material and methods: </strong>This single-center, single-blind, randomized controlled trial was conducted at a university hospital (Marmara University Faculty of Medicine, İstanbul, Türkiye) between August 2022 and May 2023. Patients received SFIB, LESPB, or no block before spinal anesthesia. No block-related complications were observed. Postoperative analgesia was provided using patient-controlled intravenous morphine, with tramadol administered as rescue analgesia for NRS pain scores above 4. The primary outcome was 24-hour total opioid consumption. Secondary outcomes included opioid consumption at 6 and 48 hours, pain scores, rescue analgesia requirements, and time to discharge from the intensive care unit and hospital.</p><p><strong>Results: </strong>A total of 63 patients (mean age 78.5±14.0 years; 46 females and 17 males) with American Society of Anesthesiologists I-III undergoing hip fracture surgery were randomized to SFIB (n=23), LESPB (n=22), or control (n=22). During the first 24 hours, opioid consumption were higher in the control group [18 (9-24.5); p=0.002]. Post-hoc analysis showed a significant difference between the control and SFIB groups [6 (4-9); p<0.001]. The LESPB [13 (5-22)] and control groups were comparable (p>0.016).</p><p><strong>Conclusion: </strong>SFIB provided the greatest reduction in postoperative opioid use during the first 24 hours after hip fracture surgery. While LESPB appears to be an alternative to SFIB, it produced a reduction in opioid consumption similar to that observed in the control group. Suprainguinal FIB should be prioritized as a component of multimodal analgesia for these surgeries.</p>","PeriodicalId":23374,"journal":{"name":"Turkish Journal of Surgery","volume":" ","pages":""},"PeriodicalIF":0.6,"publicationDate":"2026-01-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145913201","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-07DOI: 10.47717/turkjsurg.2025.2025-8-9
Gustavo Pellegrini Magaldi, Vitor Favali Kruger, Hércules Henrique Fachioli Magaldi, Elcio Shiyoiti Hirano, Vania Aparecida Leandro-Merhi, José Luis Braga de Aquino
Objective: Evaluating the diagnostic accuracy of extended focused assessment with sonography for trauma (E-FAST) for detecting pneumothorax, hemothorax, and pulmonary contusions using thoracic computed tomography (CT) as the reference standard.
Material and methods: Retrospective analysis of 202 adult thoracic trauma patients (2016-2021). E-FAST diagnostic accuracy was calculated using CT as reference standard.
Results: E-FAST was performed in 149 patients (74%), who presented with significantly higher injury severity (injury severity score: 25 vs. 17; p=0.018) and hemodynamic instability. E-FAST demonstrated 90% sensitivity for pneumothorax, 86% for hemothorax, and 95% specificity for both conditions. Positive predictive values were 92% for pneumothorax and 89% for hemothorax. E-FAST was superior to chest radiography for detecting pleural complications and facilitated immediate thoracic drainage in 39.1% of cases. Cost analysis revealed four-fold reduction compared to CT.
Conclusion: E-FAST demonstrated high diagnostic accuracy for pneumothorax and hemothorax compared to CT, while also showing superior performance to conventional radiography. E-FAST facilitates rapid bedside assessment and immediate surgical decision-making in critically injured patients. However, the significant selection bias toward critically injured patients limits the conclusions regarding the independent impact on clinical outcomes.
{"title":"Fast, accurate, and cost-effective: E-FAST's breakthrough in optimizing thoracic trauma management.","authors":"Gustavo Pellegrini Magaldi, Vitor Favali Kruger, Hércules Henrique Fachioli Magaldi, Elcio Shiyoiti Hirano, Vania Aparecida Leandro-Merhi, José Luis Braga de Aquino","doi":"10.47717/turkjsurg.2025.2025-8-9","DOIUrl":"https://doi.org/10.47717/turkjsurg.2025.2025-8-9","url":null,"abstract":"<p><strong>Objective: </strong>Evaluating the diagnostic accuracy of extended focused assessment with sonography for trauma (E-FAST) for detecting pneumothorax, hemothorax, and pulmonary contusions using thoracic computed tomography (CT) as the reference standard.</p><p><strong>Material and methods: </strong>Retrospective analysis of 202 adult thoracic trauma patients (2016-2021). E-FAST diagnostic accuracy was calculated using CT as reference standard.</p><p><strong>Results: </strong>E-FAST was performed in 149 patients (74%), who presented with significantly higher injury severity (injury severity score: 25 vs. 17; p=0.018) and hemodynamic instability. E-FAST demonstrated 90% sensitivity for pneumothorax, 86% for hemothorax, and 95% specificity for both conditions. Positive predictive values were 92% for pneumothorax and 89% for hemothorax. E-FAST was superior to chest radiography for detecting pleural complications and facilitated immediate thoracic drainage in 39.1% of cases. Cost analysis revealed four-fold reduction compared to CT.</p><p><strong>Conclusion: </strong>E-FAST demonstrated high diagnostic accuracy for pneumothorax and hemothorax compared to CT, while also showing superior performance to conventional radiography. E-FAST facilitates rapid bedside assessment and immediate surgical decision-making in critically injured patients. However, the significant selection bias toward critically injured patients limits the conclusions regarding the independent impact on clinical outcomes.</p>","PeriodicalId":23374,"journal":{"name":"Turkish Journal of Surgery","volume":" ","pages":""},"PeriodicalIF":0.6,"publicationDate":"2026-01-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145918536","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-07DOI: 10.47717/turkjsurg.2025.2025-8-19
Andrey Makarov, Natalya Korableva, Pavel Pavlov, Mikhail Dokhov
Objective: Bioresorbable poly-D-L-lactic acid (PDLLA) plates are increasingly used in rhinoseptoplasty due to their biocompatibility, adequate initial mechanical strength, and complete resorption over time. These properties may offer advantages over permanent implants, particularly in complex cases involving post-traumatic nasal deformity. To evaluate the clinical efficacy and safety of PDLLA plates in achieving functional and aesthetic outcomes in primary and reconstructive rhinoseptoplasty.
Material and methods: A retrospective cohort study was conducted on 37 consecutive patients [23 men, 14 women; median age 37 years, interquartile range (IQR) 30-44] who underwent rhinoseptoplasty between January 2022 and December 2024. The minimum follow-up was 3 months. Primary endpoints included septal stability, complication profile (e.g., infection, extrusion, resorption issues), and patient-reported outcomes. Subjective nasal appearance and symptom burden were assessed using the validated Standardized Cosmesis and Health Nasal Outcomes Survey (SCHNOS). In select cases requiring revision, histopathological evaluation of implantation sites was performed at 12 and 24 months.
Results: He use of pure PDLLA plates provided reliable septal stabilization and facilitated precise dorsal alignment, eliminating the need for autologous graft harvesting in 83.8% of cases. No plate-related infections, extrusions, or delayed resorption events were observed. Patient-reported symptom burden, as measured by the SCHNOS score, improved markedly from a median of 21 (IQR: 15-26) preoperatively to 1 (IQR: 0-1) postoperatively. Histology confirmed complete material resorption by 24 months, with mature collagenous remodeling and an absence of chronic inflammatory infiltrate.
Conclusion: In carefully selected patients, PDLLA plates appear to be a biocompatible and technically feasible adjunct in rhinoseptoplasty, facilitating septal reconstruction, eliminating donor-site morbidity, and yielding improvements in both patient-reported nasal function and aesthetic outcomes. These preliminary findings support further investigation in larger, controlled studies.
{"title":"Potential use of bioresorbable poly-D-L-lactic acid (PDLLA) plates in rhinoseptoplasty.","authors":"Andrey Makarov, Natalya Korableva, Pavel Pavlov, Mikhail Dokhov","doi":"10.47717/turkjsurg.2025.2025-8-19","DOIUrl":"https://doi.org/10.47717/turkjsurg.2025.2025-8-19","url":null,"abstract":"<p><strong>Objective: </strong>Bioresorbable poly-D-L-lactic acid (PDLLA) plates are increasingly used in rhinoseptoplasty due to their biocompatibility, adequate initial mechanical strength, and complete resorption over time. These properties may offer advantages over permanent implants, particularly in complex cases involving post-traumatic nasal deformity. To evaluate the clinical efficacy and safety of PDLLA plates in achieving functional and aesthetic outcomes in primary and reconstructive rhinoseptoplasty.</p><p><strong>Material and methods: </strong>A retrospective cohort study was conducted on 37 consecutive patients [23 men, 14 women; median age 37 years, interquartile range (IQR) 30-44] who underwent rhinoseptoplasty between January 2022 and December 2024. The minimum follow-up was 3 months. Primary endpoints included septal stability, complication profile (e.g., infection, extrusion, resorption issues), and patient-reported outcomes. Subjective nasal appearance and symptom burden were assessed using the validated Standardized Cosmesis and Health Nasal Outcomes Survey (SCHNOS). In select cases requiring revision, histopathological evaluation of implantation sites was performed at 12 and 24 months.</p><p><strong>Results: </strong>He use of pure PDLLA plates provided reliable septal stabilization and facilitated precise dorsal alignment, eliminating the need for autologous graft harvesting in 83.8% of cases. No plate-related infections, extrusions, or delayed resorption events were observed. Patient-reported symptom burden, as measured by the SCHNOS score, improved markedly from a median of 21 (IQR: 15-26) preoperatively to 1 (IQR: 0-1) postoperatively. Histology confirmed complete material resorption by 24 months, with mature collagenous remodeling and an absence of chronic inflammatory infiltrate.</p><p><strong>Conclusion: </strong>In carefully selected patients, PDLLA plates appear to be a biocompatible and technically feasible adjunct in rhinoseptoplasty, facilitating septal reconstruction, eliminating donor-site morbidity, and yielding improvements in both patient-reported nasal function and aesthetic outcomes. These preliminary findings support further investigation in larger, controlled studies.</p>","PeriodicalId":23374,"journal":{"name":"Turkish Journal of Surgery","volume":" ","pages":""},"PeriodicalIF":0.6,"publicationDate":"2026-01-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145913256","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-08Epub Date: 2025-07-29DOI: 10.47717/turkjsurg.2025.2025-3-33
Sampara Vasishta, Usha Sachidananda Adiga, Alfred J Augustine
Objective: Bladder carcinoma represents a significant challenge in oncology due to its heterogeneous molecular nature. This study aimed to identify key genetic factors and molecular pathways involved in bladder carcinoma pathogenesis to facilitate the development of targeted therapies.
Material and methods: The top 30 genes associated with bladder carcinoma were retrieved from the disease gene network database. Comprehensive bioinformatic analysis was performed using various enrichment tools, including gene ontology biological process, cellular component, molecular function analyses, and pathway mapping through WikiPathways and metabolite associations through human metabolome database. Drug interactions were evaluated using DrugMatrix data.
Results: Gene ontology analysis revealed significant enrichment of cancer-related biological processes, cellular components, and molecular functions. Pathway analysis identified strong associations with head and neck squamous cell carcinoma, cancer pathways, pleural mesothelioma, endometrial cancer, and bladder cancer pathways. Key genes including CDKN2A, PTEN, EGFR, PIK3CA, HRAS, FGFR3, and TP53 were implicated across multiple pathways. Metabolite analysis showed significant associations with phosphatidylinositol derivatives, highlighting the importance of the PI3K pathway. Drug interaction analysis revealed potential modulatory effects of several compounds including sertraline, valproic acid, and hydroxyurea on gene expression patterns in bladder carcinoma.
Conclusion: This study provides comprehensive insights into the molecular underpinnings of bladder carcinoma, highlighting interconnected pathways and potential therapeutic targets. The significant overlap with other cancer types suggests common oncogenic mechanisms that could be exploited for therapeutic intervention. Further validation of these findings in clinical samples may facilitate the development of personalized treatment approaches for bladder carcinoma patients.
{"title":"Genetic profiling and pathway analysis in bladder carcinoma: Implications for therapeutic targeting.","authors":"Sampara Vasishta, Usha Sachidananda Adiga, Alfred J Augustine","doi":"10.47717/turkjsurg.2025.2025-3-33","DOIUrl":"10.47717/turkjsurg.2025.2025-3-33","url":null,"abstract":"<p><strong>Objective: </strong>Bladder carcinoma represents a significant challenge in oncology due to its heterogeneous molecular nature. This study aimed to identify key genetic factors and molecular pathways involved in bladder carcinoma pathogenesis to facilitate the development of targeted therapies.</p><p><strong>Material and methods: </strong>The top 30 genes associated with bladder carcinoma were retrieved from the disease gene network database. Comprehensive bioinformatic analysis was performed using various enrichment tools, including gene ontology biological process, cellular component, molecular function analyses, and pathway mapping through WikiPathways and metabolite associations through human metabolome database. Drug interactions were evaluated using DrugMatrix data.</p><p><strong>Results: </strong>Gene ontology analysis revealed significant enrichment of cancer-related biological processes, cellular components, and molecular functions. Pathway analysis identified strong associations with head and neck squamous cell carcinoma, cancer pathways, pleural mesothelioma, endometrial cancer, and bladder cancer pathways. Key genes including <i>CDKN2A, PTEN, EGFR, PIK3CA, HRAS, FGFR3</i>, and <i>TP53</i> were implicated across multiple pathways. Metabolite analysis showed significant associations with phosphatidylinositol derivatives, highlighting the importance of the PI3K pathway. Drug interaction analysis revealed potential modulatory effects of several compounds including sertraline, valproic acid, and hydroxyurea on gene expression patterns in bladder carcinoma.</p><p><strong>Conclusion: </strong>This study provides comprehensive insights into the molecular underpinnings of bladder carcinoma, highlighting interconnected pathways and potential therapeutic targets. The significant overlap with other cancer types suggests common oncogenic mechanisms that could be exploited for therapeutic intervention. Further validation of these findings in clinical samples may facilitate the development of personalized treatment approaches for bladder carcinoma patients.</p>","PeriodicalId":23374,"journal":{"name":"Turkish Journal of Surgery","volume":" ","pages":"437-447"},"PeriodicalIF":0.6,"publicationDate":"2025-12-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12687403/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144733476","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-08DOI: 10.47717/turkjsurg.2025.2025-4-34
Amil Huseynov, Sevim Nuran Kuşlu Çiçek
Objective: De novo malignancy is a significant complication following kidney transplantation, attributed to prolonged immunosuppression. This study evaluates the incidence, risk factors, and clinical outcomes of de novo malignancies in kidney transplant recipients.
Material and methods: A retrospective cohort analysis was conducted on 1200 kidney transplant recipients between 2016 and 2023. Patients were categorized based on the presence or absence of de novo malignancies. Statistical analyses were performed to identify risk factors, including age, sex, comorbidities, and immunosuppressive regimens. Patient and graft survival were assessed using Kaplan-Meier analysis and the log-rank test.
Results: Among the study population, 43 patients (3.6%) developed de novo malignancies. The most frequent malignancy types were non-melanoma skin cancers (27.9%) and post-transplant lymphoproliferative disorders (18.6%). Patients with malignancies exhibited a lower three-year survival rate (83.7%) compared to those without malignancies (91.4%), though the difference was not statistically significant (p=0.067). Graft survival at three years was slightly lower in the malignancy group (84.0% vs. 88.7%, p=0.146). Older recipient age was identified as a significant risk factor (hazard ratio=1.03 per year, p=0.025).
Conclusion: De novo malignancy remains a concern in kidney transplant recipients, particularly among older patients. Regular screening protocols, lifestyle interventions, and individualized immunosuppressive regimens are essential to mitigate risk and improve outcomes.
{"title":"<i>De novo</i> malignancy development following kidney transplantation: Managing risks and outcomes in clinical practice.","authors":"Amil Huseynov, Sevim Nuran Kuşlu Çiçek","doi":"10.47717/turkjsurg.2025.2025-4-34","DOIUrl":"10.47717/turkjsurg.2025.2025-4-34","url":null,"abstract":"<p><strong>Objective: </strong><i>De novo</i> malignancy is a significant complication following kidney transplantation, attributed to prolonged immunosuppression. This study evaluates the incidence, risk factors, and clinical outcomes of <i>de novo</i> malignancies in kidney transplant recipients.</p><p><strong>Material and methods: </strong>A retrospective cohort analysis was conducted on 1200 kidney transplant recipients between 2016 and 2023. Patients were categorized based on the presence or absence of <i>de novo</i> malignancies. Statistical analyses were performed to identify risk factors, including age, sex, comorbidities, and immunosuppressive regimens. Patient and graft survival were assessed using Kaplan-Meier analysis and the log-rank test.</p><p><strong>Results: </strong>Among the study population, 43 patients (3.6%) developed <i>de novo</i> malignancies. The most frequent malignancy types were non-melanoma skin cancers (27.9%) and post-transplant lymphoproliferative disorders (18.6%). Patients with malignancies exhibited a lower three-year survival rate (83.7%) compared to those without malignancies (91.4%), though the difference was not statistically significant (p=0.067). Graft survival at three years was slightly lower in the malignancy group (84.0% vs. 88.7%, p=0.146). Older recipient age was identified as a significant risk factor (hazard ratio=1.03 per year, p=0.025).</p><p><strong>Conclusion: </strong><i>De novo</i> malignancy remains a concern in kidney transplant recipients, particularly among older patients. Regular screening protocols, lifestyle interventions, and individualized immunosuppressive regimens are essential to mitigate risk and improve outcomes.</p>","PeriodicalId":23374,"journal":{"name":"Turkish Journal of Surgery","volume":"41 4","pages":"369-373"},"PeriodicalIF":0.6,"publicationDate":"2025-12-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12687394/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145702002","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-08DOI: 10.47717/turkjsurg.2025.2025-4-9
Ekin Ulusoy, Volkan Sayur, Sarp Tunalı, Bahadır Emre Baki, Bekir Çetin, Özgür Fırat, Muhtar Sinan Ersin, Taylan Özgür Sezer
Objective: This study aimed to evaluate the effects of the coronavirus disease-2019 (COVID-19) pandemic on the diagnostic and surgical treatment processes of gastric cancer. Three-year periods before and after the pandemic were compared to examine differences in the diagnostic process, disease stage, surgical extent, and survival.
Material and methods: A retrospective analysis was conducted on 395 patients who underwent resection surgery for gastric cancer between March 11, 2017, and March 11, 2023. Patients with incomplete data regarding the diagnostic and treatment processes, those deemed inoperable following exploratory surgery and subsequently referred for alternative treatment, and patients operated on at external centers were excluded. A total of 197 patients were analyzed and divided into two groups: pre-pandemic (PP, n=137) and post-pandemic (PS, n=60).
Results: A significant decrease in the number of surgeries was observed in the PS group compared to the PP group. Significant differences were found between the two groups regarding locally advanced disease at diagnosis (T4/N+), the application rate of cytoreductive surgery+hyperthermic intraperitoneal chemotherapy, and follow-up mortality (p=0.031, p=0.028, and p=0.005). The overall mean survival was 50.02±2.78 months in the PP group and 32.52±2.24 months in the PS group (p=0.765). No significant differences were observed between the groups regarding the diagnostic process and pathological stages.
Conclusion: The COVID-19 pandemic may have reduced both the referral rates for surgery and the extent of surgical interventions for advanced-stage gastric cancer. It is believed that both surgeons and patients adopted more conservative approaches during the pandemic.
{"title":"The impact of the COVID-19 pandemic on the diagnosis and surgical treatment processes of gastric cancer.","authors":"Ekin Ulusoy, Volkan Sayur, Sarp Tunalı, Bahadır Emre Baki, Bekir Çetin, Özgür Fırat, Muhtar Sinan Ersin, Taylan Özgür Sezer","doi":"10.47717/turkjsurg.2025.2025-4-9","DOIUrl":"10.47717/turkjsurg.2025.2025-4-9","url":null,"abstract":"<p><strong>Objective: </strong>This study aimed to evaluate the effects of the coronavirus disease-2019 (COVID-19) pandemic on the diagnostic and surgical treatment processes of gastric cancer. Three-year periods before and after the pandemic were compared to examine differences in the diagnostic process, disease stage, surgical extent, and survival.</p><p><strong>Material and methods: </strong>A retrospective analysis was conducted on 395 patients who underwent resection surgery for gastric cancer between March 11, 2017, and March 11, 2023. Patients with incomplete data regarding the diagnostic and treatment processes, those deemed inoperable following exploratory surgery and subsequently referred for alternative treatment, and patients operated on at external centers were excluded. A total of 197 patients were analyzed and divided into two groups: pre-pandemic (PP, n=137) and post-pandemic (PS, n=60).</p><p><strong>Results: </strong>A significant decrease in the number of surgeries was observed in the PS group compared to the PP group. Significant differences were found between the two groups regarding locally advanced disease at diagnosis (T4/N+), the application rate of cytoreductive surgery+hyperthermic intraperitoneal chemotherapy, and follow-up mortality (p=0.031, p=0.028, and p=0.005). The overall mean survival was 50.02±2.78 months in the PP group and 32.52±2.24 months in the PS group (p=0.765). No significant differences were observed between the groups regarding the diagnostic process and pathological stages.</p><p><strong>Conclusion: </strong>The COVID-19 pandemic may have reduced both the referral rates for surgery and the extent of surgical interventions for advanced-stage gastric cancer. It is believed that both surgeons and patients adopted more conservative approaches during the pandemic.</p>","PeriodicalId":23374,"journal":{"name":"Turkish Journal of Surgery","volume":"41 4","pages":"391-397"},"PeriodicalIF":0.6,"publicationDate":"2025-12-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12687405/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145701972","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}